Objective: To study the outcome of phacoemulsification and intraocular lens implantation combined with trabeculotomy. Methods: We performed trabeculotomy combined with phacoemulsification and foldable lens implantation in 25 eyes with open-angle glaucoma and coexisting cataract in 18 patients. The series comprised 9 males (13 eyes) and 9 females (12 eyes). Mean age of the patients was 73.4 ± 10.9 years (45–87 years). Mean follow-up period was 14.3 ± 6.0 months (6–24 months). Results: The preoperative intraocular pressure was 21.4 ± 3.7 mm Hg. The postoperative intraocular pressure 6 months after the surgery was 12.8 ± 3.4 mm Hg. A postoperative tension spike (>30 mm Hg) was observed in 2 eyes. Six months after the operation, the intraocular pressure was controlled under 21 mm Hg in all eyes, and under 16 mm Hg in 18 eyes. The medication score (one point per antiglaucomatous medication) was 2.0 ± 1.6 before the surgery and 0.4 ± 0.7 after the surgery. The mean refractive error after the operation was –0.8 ± 0.7 D (range –2.4 to 0 D). The deviation of the actual refractive error from the predicted one was +0.29 ± 0.54 D (range –0.52 to +1.10 D). Conclusion: The outcome of the combined operation for open-angle glaucoma and coexisting cataract was promising.

Keywords:
Trabeculotomy, Open-angle glaucoma, Cataract, Combined surgery, Intraocular lens
1.
Gimbel HV, Meyer D, Debroff BM, Roux CW, Ferensowicz M: Intraocular pressure response to combined phacoemulsification and trabeculotomy ab externo versus phacoemulsification alone in primary open-angle glaucoma. J Cataract Refract Surg 1995;21:653–660.
2.
Saito Y, Oo A, Okamoto S, Kuwayama Y, Nakatani H: Glaucoma triple procedure comprising trabeculotomy with a fornix-based scleral flap. Doc Ophthalmol 1995;89:393–400.
3.
Cohen JS, Greff LJ, Novack GD, Wind BE: A placebo-controlled, double-masked evaluation of mitomycin C in combined glaucoma and cataract procedures. Ophthalmology 1996;103:1934–1942.
4.
Shin DH, Hughes BA, Song MS, Kim C, Yang KJ, Shah MI, Juzych MS, Obertynski T: Primary glaucoma triple procedure with or without adjunctive mitomycin. Prognostic factors for filtration failure. Ophthalmology 1996;103:1925–1933.
5.
Berestka JS, Brown SV: Limbus- versus fornix-based conjunctival flaps in combined phacoemulsification and mitomycin C trabeculectomy surgery. Ophthalmology 1997;104:187–196.
6.
Carlson DW, Alward WLM, Barad JP, Zimmerman MB, Carney BL: A randomized study of mitomycin augmentation in combined phacoemulsification and trabeculectomy. Ophthalmology 1997;104:719–724.
7.
Nielsen PJ: Combined small-incision cataract surgery and trabeculectomy: A prospective study with 1 year of follow-up. Ophthalmic Surg Lasers 1997;28:21–29.
8.
Tanihara H, Honjo M, Inatani M, Honda Y, Ogino N, Ueno S, Negi A, Ichioka H, Mizoguchi T, Matsumura M, Nagata M: Trabeculotomy combined with phacoemulsification and implantation of an intraocular lens for the treatment of primary open-angle glaucoma and coexisting cataract. Ophthalmic Surg Lasers 1997;28:810–817.
9.
Honjo M, Tanihara H, Inatani M, Honda Y, Ogino N, Ueno S, Negi A, Ichioka H, Mizoguchi T, Matsumura M, Nagata M: Phacoemulsification, intraocular lens implantation, and trabeculotomy to treat pseudoexfoliation syndrome. J Cataract Refract Surg 1998;24:781–786.
10.
Storr-Paulsen A, Pedersen JH, Laugesen C: A prospective study of combined phacoemulsification-trabeculectomy versus conventional phacoemulsification in cataract patients with coexisting open-angle glaucoma. Acta Ophthalmol Scand 1998;76:696–699.
11.
Wyse T, Meyer M, Ruderman JM, Krupin T, Talluto D, Hernandez R, Rosenberg LF: Combined trabeculectomy and phacoemulsification: A one-site vs a two-site approach. Am J Ophthalmol 1998;125:334–339.
12.
Caporossi A, Casprini F, Tosi GM, Balestrazzi A: Long-term results of combined 1-way phacoemulsification, intraocular lens implantation, and trabeculectomy. J Cataract Refract Surg 1999;25:1641–1645.
13.
Gimbel HV, Penno EE, Ferensowicz M: Combined cataract surgery, intraocular lens implantation, and viscocanalostomy. J Cataract Refract Surg 1999;25:1370–1375.
14.
Shingleton BJ, Chaudhry IM, O’Donoghue MW, Baylus SL, King RJ, Chaudhry MB: Phacotrabeculectomy: Limbus-based versus fornix-based conjunctival flaps in fellows eyes. Ophthalmology 1999;106:1152–1155.
15.
Friedman DS, Jaympel HD, Lubomski LH, Kempen JH, Quigley H, Congdon N, Levkovitch-Verbin H, Robinson KA, Bass EB: Surgical strategies for coexisting glaucoma and cataract. An evidence-based update. Ophthalmology 2002;109:1902–1915.
16.
Tanito M, Ohira A, Chihara E: Surgical outcome of combined trabeculotomy and cataract surgery. J Glaucoma 2001;10:302–308.
17.
Tanihara H, Negi A, Akimoto M, Nagata M: Surgical effects of trabeculotomy ab externo on adult eyes with primary open-angle glaucoma and pseudoexfoliation syndrome. Arch Ophthalmol 1993;111:1653–1661.
18.
Azuara-Blanco A, Katz LJ: Dysfunction filtering blebs. Surv Ophthalmol 1998;43:93–126.
19.
Greve EL, Geijssen HC: The relation between excavation and visual field in glaucoma patients with high and with low intraocular pressure. Doc Ophthalmol Proc Ser 1983;35:35–42.
20.
Randolph ME, Maumenee AK: Cataract extraction in glaucomatous eyes. Am J Ophthalmol 1971;71:328–330.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.